Dr. Christiane Maxien is a partner in the law firm Wallinger Ricker Schlotter Tostmann. As a chemist with a doctorate, she specializes in the technical fields of chemistry, green technologies, material sciences, and biochemistry.
Dr. Christiane Maxien holds a Bachelor of Science (B.Sc.) degree in chemistry and biochemistry from Ludwig-Maximilians-University Munich (LMU) and in 2006 she graduated with a Master of Science degree in chemistry. Her main fields of study were pharmaceutical chemistry, organic chemistry (stereoselective synthesis, synthesis of natural products and antibiotics), macromolecular chemistry (polymer and dye chemistry) and inorganic chemistry (fluorine chemistry, high-energy materials, solid state chemistry, molecular inorganic chemistry). Her master's thesis dealt, among other things, with the synthesis of new ionic liquids as reaction media for unstable phosphorus compounds. Dr. Maxien was awarded the Dr. Römer Prize for her master's thesis.
Dr. Maxien completed her doctorate at the Chair of Inorganic Chemistry at LMU in 2009 with the distinction "summa cum laude". The doctoral thesis focused on the development of new chalcogenophosphates and the investigation of their chemical properties, particularly with regard to the application of these compounds in modern, highly-efficient lithium-ion rechargeable batteries.
Dr. Maxien joined the firm’s team in 2010, first as a Patent Attorney trainee, and since 2013 as a Patent Attorney and since 2014 as a European Patent Attorney. In 2018, she became the first woman and youngest partner to join the partnership at Wallinger Ricker Schlotter Tostmann.
Dr. Maxien specializes in assisting and advising clients with international operations, particularly with regard to commercially viable patent portfolio management. Her practice areas include patent prosecution in Germany and Europe, coordination of patent prosecution in countries outside Europe, and enforcement and defense of intellectual property rights, in particular in opposition and appeal proceedings before the European Patent Office, as well as the preparation of freedom-to-operate opinions.
Furthermore, Dr. Maxien is involved in Science4life and in the IBB network for industrial biotechnology in Bavaria for start-ups and SMEs in patent law issues and in the evaluation of business plans with her Patent Attorney expertise.
